{
    "article_link": "https://doi.org/10.1038/s41586-021-04278-5",
    "data": [
        {
            "id": "data_1",
            "omics": "Genomics",
            "link": "https://ega-archive.org/datasets/EGAS00001004582",
            "format": "BAM",
            "source": "European Genome-Phenome Archive (EGA)",
            "public_id": "EGAS00001004582"
        },
        {
            "id": "data_2",
            "omics": "Transcriptomics",
            "link": "https://ega-archive.org/datasets/EGAS00001004582",
            "format": "TPM",
            "source": "European Genome-Phenome Archive (EGA)",
            "public_id": "EGAS00001004582"
        },
        {
            "id": "data_3",
            "omics": "Digital Pathology",
            "link": "null",
            "format": "Processed Data",
            "source": "null",
            "public_id": "null"
        }
    ],
    "analyses": [
        {
            "id": "analysis_1",
            "analysis_name": "Multi-omic Machine Learning Model",
            "analysis_data": [
                "data_1",
                "data_2",
                "data_3"
            ],
            "label": {
                "RCB_class": [
                    "pCR",
                    "RCB-I",
                    "RCB-II",
                    "RCB-III"
                ]
            }
        },
        {
            "id": "analysis_2",
            "analysis_name": "Differential Gene Expression Analysis",
            "analysis_data": [
                "data_2"
            ],
            "label": {
                "RCB_class": [
                    "pCR",
                    "residual_disease"
                ]
            }
        },
        {
            "id": "analysis_3",
            "analysis_name": "Gene Set Enrichment Analysis (GSEA)",
            "analysis_data": [
                "data_2"
            ],
            "label": {
                "RCB_class": [
                    "pCR",
                    "RCB-I",
                    "RCB-II",
                    "RCB-III"
                ]
            }
        },
        {
            "id": "analysis_4",
            "analysis_name": "Mutational Signature Decomposition",
            "analysis_data": [
                "data_1"
            ],
            "label": {
                "HER2_status": [
                    "HER2-",
                    "HER2+"
                ]
            }
        },
        {
            "id": "analysis_5",
            "analysis_name": "T Cell Dysfunction and Exclusion Metrics",
            "analysis_data": [
                "data_2"
            ],
            "label": {
                "HER2_status": [
                    "HER2-",
                    "HER2+"
                ]
            },
            "link": "http://tide.dfci.harvard.edu"
        }
    ],
    "results": [
        {
            "analysis_id": "analysis_1",
            "metrics": "AUC",
            "value": "0.87",
            "features": [
                "TP53 mutations",
                "tumor mutation burden",
                "chromosomal instability",
                "HLA LOH",
                "T cell dysfunction",
                "T cell exclusion"
            ]
        },
        {
            "analysis_id": "analysis_2",
            "metrics": "Fold Change",
            "value": "null",
            "features": [
                "CDKN2A",
                "EGFR",
                "CCNE1",
                "MYC",
                "CCND1",
                "ZNF703",
                "ESR1"
            ]
        },
        {
            "analysis_id": "analysis_3",
            "metrics": "Normalized Enrichment Score",
            "value": "null",
            "features": [
                "Proliferation",
                "Immune activation",
                "E2F targets",
                "MYC targets v1",
                "IFNÎ³ response"
            ]
        },
        {
            "analysis_id": "analysis_4",
            "metrics": "Odds Ratio",
            "value": "1.1 (HRD), 1.1 (APOBEC)",
            "features": [
                "Homologous recombination deficiency (HRD)",
                "APOBEC mutational signature"
            ]
        },
        {
            "analysis_id": "analysis_5",
            "metrics": "Wilcoxon P-value",
            "value": "0.006 (T cell dysfunction), 0.0009 (T cell exclusion)",
            "features": [
                "Regulatory T cells",
                "M2 tumor-associated macrophages",
                "Cancer-associated fibroblasts"
            ]
        }
    ]
}